Natural Health Trends Corp.
NHTC · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 49.13M | 36.47M | -270.00K | 313.00K | 0.03 |
| 2023 FY | 43.92M | 32.75M | -1.67M | 568.00K | 0.05 |
| 2024 FY | 42.96M | 31.79M | -1.30M | 572.00K | 0.05 |
| 2025 FY | 39.78M | 29.25M | -1.81M | -882.00K | -0.08 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 82.82M | 32.67M | 69.67M | 4.12M | 50.15M |
| 2023 FY | 69.09M | 27.49M | 56.18M | 3.46M | 41.60M |
| 2024 FY | 55.36M | 22.49M | 13.53M | 2.64M | 32.87M |
| 2025 FY | 38.43M | 15.00M | 6.81M | 3.13M | 23.43M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -4.85M | -143.00K | -5.00M | -9.14M | -14.62M |
| 2023 FY | -4.28M | -46.00K | -4.32M | -9.22M | -13.53M |
| 2024 FY | -3.37M | -57.00K | -3.42M | -9.21M | -42.65M |
| 2025 FY | -6.00M | -68.00K | -6.07M | -9.21M | -6.75M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 38.97M | -26.57M | — | — | — |
| 2023 FY | 67.01M | 14.30M | — | — | — |
| 2024 FY | 52.98M | 42.09M | — | — | — |
| 2025 FY | 35.52M | 31.84M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 9.81M | 7.26M | -333.00K | 15.00K | 0.00 |
| 2025 Q3 | 9.48M | 6.99M | -495.00K | -431.00K | -0.04 |
| 2025 Q4 | 9.75M | 7.11M | -635.00K | -588.00K | -0.05 |
| 2026 Q1 | 9.21M | 6.89M | -474.00K | -154.00K | -0.02 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 45.16M | 16.31M | 10.53M | 2.25M | 28.86M |
| 2025 Q3 | 42.25M | 16.10M | 14.34M | 3.34M | 26.15M |
| 2025 Q4 | 38.43M | 15.00M | 6.81M | 3.13M | 23.43M |
| 2026 Q1 | 31.95M | 15.49M | 9.22M | 3.02M | 16.46M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -5.64M | -4.00K | -5.64M | -2.30M | -11.15M |
| 2025 Q3 | 113.00K | -43.00K | 70.00K | -2.30M | 3.80M |
| 2025 Q4 | 183.00K | -5.00K | 178.00K | -2.30M | -7.52M |
| 2026 Q1 | -797.00K | -115.00K | -912.00K | -858.00K | 2.41M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 49.76M | 41.48M | — | — | — |
| 2025 Q3 | 51.41M | 40.41M | — | — | — |
| 2025 Q4 | 35.56M | 31.87M | — | — | — |
| 2026 Q1 | 28.30M | 22.10M | — | — | — |